Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study

Wasehuus, Victor; Rotbain Curovic, Viktor; Tofte, Nete; Lindhardt, Morten; Currie, Gemma; Delles, Christian; Frimodt-Møller, Marie; Mischak, Harald; von der Leyen, Heiko; Hansen, Tine Willum; Kümler, Thomas; Persson, Frederik; Rossing, Peter; the PRIORITY Study group; Spasovski, Goce; Adamova, Katarina; Gjorgovski, Tatjana; Selim, Gjulshen; Shubeska Stratrova, Slavica; Stojcheva Taneva, Olivera

doi:10.1111/dom.16037

Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY study

Journal

Diabetes, Obesity and Metabolism

Date Issued

2025-01

Author(s)

Wasehuus, Victor

Rotbain Curovic, Viktor

Tofte, Nete

Lindhardt, Morten

Currie, Gemma

Delles, Christian

Frimodt-Møller, Marie

Mischak, Harald

von der Leyen, Heiko

Hansen, Tine Willum

Kümler, Thomas

Persson, Frederik

Rossing, Peter

the PRIORITY Study group

Adamova, Katarina

Gjorgovski, Tatjana

DOI

10.1111/dom.16037

Abstract

This study aimed to explore the effect of discontinuation of long-term spironolactone treatment on markers of kidney function in individuals with type 2 diabetes (T2D) at high risk of kidney disease enrolled in the Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria (PRIORITY) study.

File(s)

Name

dom16037-sup-0001-appendix.docx

Size

36.28 KB

Format

Microsoft Word XML

Checksum

(MD5):0418c950f988a24b00fa2d124b673403